Moderate riskFDA DrugClass II

OneSource methohexital injection recalled for impurity failure

OneSource Specialty Pharma Limited is recalling one lot of Methohexital Sodium for Injection, USP 500 mg multiple dose vials, manufactured for Avet Pharmaceuticals Inc. The product failed impurities and degradation specifications. The notice reports 4,284 vials distributed nationwide and no injuries.

From the FDA notice · Read the official notice ↗

What to do

  1. Set aside lot 7000612A (exp. 1/2028) of the 500 mg multiple dose vials, NDC 23155-893-31, and do not administer it.
  2. Contact Avet Pharmaceuticals Inc. about the recall. The notice doesn't say how to get a replacement or refund.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31
Sold in
Nationwide
Made for
All ages (0 months and older)

Details

Units affected
4284 vials
Illnesses reported
None reported
Manufactured in
Plot No.: 2-D1, Obadenahalli Industrial Area, Doddaballapura, 3rd Phase; Kasa, Doddaballapura Taluk, Bengaluru, N/A, India
Classification
Class II
Recall number
D-0662-2026

In the FDA's words

Description
Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31 Failed Impurities/Degradation Specifications Lot #: 7000612A, Exp. Date 1/2028 Distribution: Nationwide within the United States Affected quantity: 4284 vials
Hazard
Failed Impurities/Degradation Specifications

Related topics

Industrial chemicalsDrugsSold nationwideMore from FDA Drug